Drug Information

The following information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Drug Name: Ocuflox (ofloxacin opthalmic solution) 0.3%

Company: Allergan
Approval Status: Approved May 1996
Treatment Area: corneal ulcers

General Information

Ocuflox has been approved for the treatment of corneal ulcers. The approval also supports the broader use of Ocuflox, which is already indicated for the treatment of bacterial conjunctivitis. Ocuflox is part of a class of anti-bacterial agents called fluoroquinolones that exhibit a broad spectrum of activity, low resistance, and favorable side-effects profile.